The global market for Network Point-of-Care Glucose Testing Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Network Point-of-Care Glucose Testing Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Network Point-of-Care Glucose Testing Device by region & country, by Type, and by Application.
The Network Point-of-Care Glucose Testing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Network Point-of-Care Glucose Testing Device.
麻豆原创 Segmentation
By Company
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
Segment by Type:
0.5uL/0.6uL
1uL
1.5uL
Others
Segment by Application
Hospital
Clinic
Household
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Network Point-of-Care Glucose Testing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Network Point-of-Care Glucose Testing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Network Point-of-Care Glucose Testing Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Network Point-of-Care Glucose Testing Device Product Introduction
1.2 Global Network Point-of-Care Glucose Testing Device 麻豆原创 Size Forecast
1.2.1 Global Network Point-of-Care Glucose Testing Device Sales Value (2019-2030)
1.2.2 Global Network Point-of-Care Glucose Testing Device Sales Volume (2019-2030)
1.2.3 Global Network Point-of-Care Glucose Testing Device Sales Price (2019-2030)
1.3 Network Point-of-Care Glucose Testing Device 麻豆原创 Trends & Drivers
1.3.1 Network Point-of-Care Glucose Testing Device Industry Trends
1.3.2 Network Point-of-Care Glucose Testing Device 麻豆原创 Drivers & Opportunity
1.3.3 Network Point-of-Care Glucose Testing Device 麻豆原创 Challenges
1.3.4 Network Point-of-Care Glucose Testing Device 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Network Point-of-Care Glucose Testing Device Players Revenue Ranking (2023)
2.2 Global Network Point-of-Care Glucose Testing Device Revenue by Company (2019-2024)
2.3 Global Network Point-of-Care Glucose Testing Device Players Sales Volume Ranking (2023)
2.4 Global Network Point-of-Care Glucose Testing Device Sales Volume by Company Players (2019-2024)
2.5 Global Network Point-of-Care Glucose Testing Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Network Point-of-Care Glucose Testing Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Network Point-of-Care Glucose Testing Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Network Point-of-Care Glucose Testing Device
2.9 Network Point-of-Care Glucose Testing Device 麻豆原创 Competitive Analysis
2.9.1 Network Point-of-Care Glucose Testing Device 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Network Point-of-Care Glucose Testing Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Network Point-of-Care Glucose Testing Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.5uL/0.6uL
3.1.2 1uL
3.1.3 1.5uL
3.1.4 Others
3.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Type
3.2.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Network Point-of-Care Glucose Testing Device Sales Value, by Type (2019-2030)
3.2.3 Global Network Point-of-Care Glucose Testing Device Sales Value, by Type (%) (2019-2030)
3.3 Global Network Point-of-Care Glucose Testing Device Sales Volume by Type
3.3.1 Global Network Point-of-Care Glucose Testing Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Network Point-of-Care Glucose Testing Device Sales Volume, by Type (2019-2030)
3.3.3 Global Network Point-of-Care Glucose Testing Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Network Point-of-Care Glucose Testing Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Household
4.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Application
4.2.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Network Point-of-Care Glucose Testing Device Sales Value, by Application (2019-2030)
4.2.3 Global Network Point-of-Care Glucose Testing Device Sales Value, by Application (%) (2019-2030)
4.3 Global Network Point-of-Care Glucose Testing Device Sales Volume by Application
4.3.1 Global Network Point-of-Care Glucose Testing Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Network Point-of-Care Glucose Testing Device Sales Volume, by Application (2019-2030)
4.3.3 Global Network Point-of-Care Glucose Testing Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Network Point-of-Care Glucose Testing Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Region
5.1.1 Global Network Point-of-Care Glucose Testing Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Network Point-of-Care Glucose Testing Device Sales Value by Region (2019-2024)
5.1.3 Global Network Point-of-Care Glucose Testing Device Sales Value by Region (2025-2030)
5.1.4 Global Network Point-of-Care Glucose Testing Device Sales Value by Region (%), (2019-2030)
5.2 Global Network Point-of-Care Glucose Testing Device Sales Volume by Region
5.2.1 Global Network Point-of-Care Glucose Testing Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Network Point-of-Care Glucose Testing Device Sales Volume by Region (2019-2024)
5.2.3 Global Network Point-of-Care Glucose Testing Device Sales Volume by Region (2025-2030)
5.2.4 Global Network Point-of-Care Glucose Testing Device Sales Volume by Region (%), (2019-2030)
5.3 Global Network Point-of-Care Glucose Testing Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
5.4.2 North America Network Point-of-Care Glucose Testing Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
5.5.2 Europe Network Point-of-Care Glucose Testing Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
5.6.2 Asia Pacific Network Point-of-Care Glucose Testing Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
5.7.2 South America Network Point-of-Care Glucose Testing Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Network Point-of-Care Glucose Testing Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Network Point-of-Care Glucose Testing Device Sales Value
6.2.1 Key Countries/Regions Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Network Point-of-Care Glucose Testing Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.3.2 United States Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.4.2 Europe Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.5.2 China Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.6.2 Japan Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.7.2 South Korea Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.8.2 Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Network Point-of-Care Glucose Testing Device Sales Value, 2019-2030
6.9.2 India Network Point-of-Care Glucose Testing Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Network Point-of-Care Glucose Testing Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche Holding AG
7.1.1 Roche Holding AG Company Information
7.1.2 Roche Holding AG Introduction and Business Overview
7.1.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Offerings
7.1.5 Roche Holding AG Recent Development
7.2 Ascensia Diabetes Care Holdings AG
7.2.1 Ascensia Diabetes Care Holdings AG Company Information
7.2.2 Ascensia Diabetes Care Holdings AG Introduction and Business Overview
7.2.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Offerings
7.2.5 Ascensia Diabetes Care Holdings AG Recent Development
7.3 Nova Biomedical
7.3.1 Nova Biomedical Company Information
7.3.2 Nova Biomedical Introduction and Business Overview
7.3.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Offerings
7.3.5 Nova Biomedical Recent Development
7.4 LifeScan, Inc.
7.4.1 LifeScan, Inc. Company Information
7.4.2 LifeScan, Inc. Introduction and Business Overview
7.4.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Offerings
7.4.5 LifeScan, Inc. Recent Development
7.5 Danaher Corporation
7.5.1 Danaher Corporation Company Information
7.5.2 Danaher Corporation Introduction and Business Overview
7.5.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Offerings
7.5.5 Danaher Corporation Recent Development
7.6 Prodigy Diabetes Care
7.6.1 Prodigy Diabetes Care Company Information
7.6.2 Prodigy Diabetes Care Introduction and Business Overview
7.6.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Offerings
7.6.5 Prodigy Diabetes Care Recent Development
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Information
7.7.2 Johnson & Johnson Introduction and Business Overview
7.7.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Offerings
7.7.5 Johnson & Johnson Recent Development
7.8 Nipro
7.8.1 Nipro Company Information
7.8.2 Nipro Introduction and Business Overview
7.8.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nipro Network Point-of-Care Glucose Testing Device Product Offerings
7.8.5 Nipro Recent Development
7.9 ACON Laboratories, Inc.
7.9.1 ACON Laboratories, Inc. Company Information
7.9.2 ACON Laboratories, Inc. Introduction and Business Overview
7.9.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Offerings
7.9.5 ACON Laboratories, Inc. Recent Development
7.10 Trividia Health, Inc.
7.10.1 Trividia Health, Inc. Company Information
7.10.2 Trividia Health, Inc. Introduction and Business Overview
7.10.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Offerings
7.10.5 Trividia Health, Inc. Recent Development
7.11 Panasonic Healthcare Holdings
7.11.1 Panasonic Healthcare Holdings Company Information
7.11.2 Panasonic Healthcare Holdings Introduction and Business Overview
7.11.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Offerings
7.11.5 Panasonic Healthcare Holdings Recent Development
7.12 EKF Diagnostics
7.12.1 EKF Diagnostics Company Information
7.12.2 EKF Diagnostics Introduction and Business Overview
7.12.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.12.4 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Offerings
7.12.5 EKF Diagnostics Recent Development
7.13 Omron
7.13.1 Omron Company Information
7.13.2 Omron Introduction and Business Overview
7.13.3 Omron Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Omron Network Point-of-Care Glucose Testing Device Product Offerings
7.13.5 Omron Recent Development
7.14 B. Braun
7.14.1 B. Braun Company Information
7.14.2 B. Braun Introduction and Business Overview
7.14.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.14.4 B. Braun Network Point-of-Care Glucose Testing Device Product Offerings
7.14.5 B. Braun Recent Development
7.15 77 Elektronika
7.15.1 77 Elektronika Company Information
7.15.2 77 Elektronika Introduction and Business Overview
7.15.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.15.4 77 Elektronika Network Point-of-Care Glucose Testing Device Product Offerings
7.15.5 77 Elektronika Recent Development
7.16 AgaMatrix
7.16.1 AgaMatrix Company Information
7.16.2 AgaMatrix Introduction and Business Overview
7.16.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.16.4 AgaMatrix Network Point-of-Care Glucose Testing Device Product Offerings
7.16.5 AgaMatrix Recent Development
7.17 Terumo
7.17.1 Terumo Company Information
7.17.2 Terumo Introduction and Business Overview
7.17.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Terumo Network Point-of-Care Glucose Testing Device Product Offerings
7.17.5 Terumo Recent Development
8 Industry Chain Analysis
8.1 Network Point-of-Care Glucose Testing Device Industrial Chain
8.2 Network Point-of-Care Glucose Testing Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Network Point-of-Care Glucose Testing Device Sales Model
8.5.2 Sales Channel
8.5.3 Network Point-of-Care Glucose Testing Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
听
听
*If Applicable.
